AI’s Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

0 Recensioner
0
Episod
753 of 967
Längd
19min
Språk
Engelska
Format
Kategori
Ekonomi & Business

Today’s guest is Ramesh Durvasula, Senior Vice President of R&D IT at Lilly. Ramesh joins us on the program today to discuss AI’s impact on the drug targeting process, particularly in helping pharmaceutical leaders like Lilly better predict what potential drugs to invest in for bringing to market and when. With increased certainty in drug targeting, Ramesh explains how AI capabilities are driving clinical trials to be used as an alternative form of healthcare. Visit emerj.com/beg1 to learn more about the practical steps for AI deployment for non-technical professionals.


Lyssna när som helst, var som helst

Kliv in i en oändlig värld av stories

  • 1 miljon stories
  • Hundratals nya stories varje vecka
  • Få tillgång till exklusivt innehåll
  • Avsluta när du vill
Starta erbjudandet
SE - Details page - Device banner - 894x1036

Andra podcasts som du kanske gillar...